1. Home
  2. SHIM vs MDCX Comparison

SHIM vs MDCX Comparison

Compare SHIM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.82

Market Cap

149.2M

Sector

N/A

ML Signal

HOLD

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

N/A

Current Price

$0.27

Market Cap

15.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIM
MDCX
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
149.2M
15.9M
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
SHIM
MDCX
Price
$3.82
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
83.0K
1.7M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
N/A
EPS
N/A
N/A
Revenue
$492,844,000.00
N/A
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.95
$0.24
52 Week High
$6.76
$3.05

Technical Indicators

Market Signals
Indicator
SHIM
MDCX
Relative Strength Index (RSI) 48.85 41.75
Support Level $3.44 $0.26
Resistance Level $4.09 $0.36
Average True Range (ATR) 0.30 0.03
MACD -0.03 -0.00
Stochastic Oscillator 25.42 25.26

Price Performance

Historical Comparison
SHIM
MDCX

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: